Skip to main content

Enoxacin Pregnancy and Breastfeeding Warnings

Brand names: Penetrex

Enoxacin Pregnancy Warnings

Enoxacin has been assigned to pregnancy category C. Some animal studies failed to reveal evidence of teratogenicity; however, at high doses there was evidence of maternal toxicity and fetotoxicity. There are no controlled data in human pregnancies. Cartilage damage and arthropathies are reported in immature animals giving rise to concern over effects on fetal bone formation. Enoxacin should only be given during pregnancy when benefit outweighs risk.

See references

Enoxacin Breastfeeding Warnings

It is not known whether enoxacin is excreted in human milk. Cartilage damage and arthropathies have been reported in immature animals, giving rise to concern over adverse effects in a nursing infant. Enoxacin use during lactation should be avoided until more data are available.

See references

See also

References for pregnancy information

  1. (2002) "Product Information. Penetrex (enoxacin)." Rhone Poulenc Rorer
  2. Ramakrishnan K, Scheid DC (2005) "Diagnosis and management of acute pyelonephritis in adults." Am Fam Physician, 71, p. 933-42

References for breastfeeding information

  1. (2002) "Product Information. Penetrex (enoxacin)." Rhone Poulenc Rorer

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer